Literature DB >> 26231680

Systematic Review by Multivariate Meta-analyses on the Possible Role of Tumor Necrosis Factor-α Gene Polymorphisms in Association with Ischemic Stroke.

Yu-Ming Niu1, Hong Weng2, Chao Zhang3, Rui-Xia Yuan4, Jin-Zhu Yan5, Xiang-Yu Meng2, Jie Luo6.   

Abstract

A number of studies have investigated the association between tumor necrosis factor (TNF)-α gene polymorphisms and ischemic stroke susceptibility. However, results of different individual studies are often inconsistent. To provide a more robust evaluation of the association between polymorphisms of the TNF-α gene and ischemic stroke risk, we performed a systematic review with multivariate meta-analyses. PubMed, Embase, CNKI, and WanFang databases were searched up to December 20, 2014. Two reviewers independently extracted information and assessed quality of included studies after all the eligible studies were identified. Afterward, multivariate meta-analyses were performed using Stata 13. The estimation of polymorphisms and disease risk was presented by odds ratios (ORs) and corresponding 95 % confidence intervals (CIs). Forty-nine eligible case-control studies from 25 articles that explored the association between 10 TNF-α polymorphisms and ischemic stroke were indentified from aforementioned databases. The results of multivariate meta-analysis showed a significant association between -238G/A polymorphism (4760 patients and 4389 controls) and ischemic stroke risk in heterozygotes compared with wild genotype (AG vs. GG: OR 1.44, 95 % CI 1.11-1.87; AA vs. GG: OR 1.98, 95 % CI 0.73-5.40). No significant association of -308G/A, -857C/T, and -1031T/C polymorphisms was observed. The results of stratification analyses of -238G/A polymorphism showed that the AG genotype only increased the risk of ischemic stroke in Asians compared to GG genotype. No additional significant association was observed in this study. In conclusion, the present systematic review and meta-analysis support a prominent role of the TNF-α -238G/A polymorphism in the risk of ischemic stroke in Asian adults only, but do not support the role of -308G/A, -857C/T, -1031T/C, -244G/A, -367G/A, -646G/A, -806C/T, -863C/A, and +448G/A in the risk of ischemic stroke. The current evidence warrants further studies with high quality and large sample size to confirm.

Entities:  

Keywords:  Ischemic stroke; Meta-analysis; Polymorphism; Systematic reviews; Tumor necrosis factor-alpha

Mesh:

Substances:

Year:  2015        PMID: 26231680     DOI: 10.1007/s12017-015-8365-7

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  36 in total

1.  Bayesian implementation of a genetic model-free approach to the meta-analysis of genetic association studies.

Authors:  Cosetta Minelli; John R Thompson; Keith R Abrams; Paul C Lambert
Journal:  Stat Med       Date:  2005-12-30       Impact factor: 2.373

2.  A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study.

Authors:  S Rubattu; R Speranza; M Ferrari; A Evangelista; M Beccia; R Stanzione; G E Assenza; M Volpe; M Rasura
Journal:  Eur J Neurol       Date:  2005-12       Impact factor: 6.089

Review 3.  Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis.

Authors:  Tiago V Pereira; Martina Rudnicki; Rendrik F Franco; Alexandre C Pereira; José E Krieger
Journal:  Am Heart J       Date:  2007-05       Impact factor: 4.749

4.  Generalized least squares for assessing trends in cumulative meta-analysis with applications in genetic epidemiology.

Authors:  Pantelis G Bagos; Georgios K Nikolopoulos
Journal:  J Clin Epidemiol       Date:  2009-04-05       Impact factor: 6.437

5.  A unification of multivariate methods for meta-analysis of genetic association studies.

Authors:  Pantelis G Bagos
Journal:  Stat Appl Genet Mol Biol       Date:  2008-10-24

6.  Genetic risk factors for perinatal arterial ischemic stroke.

Authors:  Amy A Gelfand; Lisa A Croen; Anthony R Torres; Yvonne W Wu
Journal:  Pediatr Neurol       Date:  2013-01       Impact factor: 3.372

7.  Association of tumor necrosis factor-α and matrix metalloproteinase-3 gene variants with stroke.

Authors:  A Munshi; K Rajeshwar; S Kaul; A Al-Hazzani; A A Alshatwi; G Shafi; N Balakrishna; A Jyothy
Journal:  Eur J Neurol       Date:  2011-01-11       Impact factor: 6.089

8.  Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke.

Authors:  Guanglin Cui; Haoran Wang; Rui Li; Lina Zhang; Zongzhe Li; Yan Wang; Rutai Hui; Hu Ding; Dao Wen Wang
Journal:  J Neuroinflammation       Date:  2012-10-10       Impact factor: 8.322

9.  Polymorphism -238 G/A of tumor necrosis factor alpha gene promoter is a genetic risk factor for ischemic cerebrovascular disease.

Authors:  Pilar Llamas Sillero; Jaime Fernández de Velasco Casarrubios; Arantxa García-Raso; Elena Meseguer Gancedo; Ana Belen Santos Montero; José F Tomás Martínez
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

10.  The role of genetic polymorphisms of the Renin-Angiotensin System in renal diseases: A meta-analysis.

Authors:  Georgia G Braliou; Athina-Maria G Grigoriadou; Panagiota I Kontou; Pantelis G Bagos
Journal:  Comput Struct Biotechnol J       Date:  2014-06-11       Impact factor: 7.271

View more
  10 in total

Review 1.  Genomics of Atrial Fibrillation.

Authors:  Alejandra Gutierrez; Mina K Chung
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

2.  Genetic association between TNF-α -857 C/T polymorphism and ankylosing spondylitis susceptibility: evidence from a meta-analysis.

Authors:  Yong Li; Hong-Bo Tang; Jing Bian; Bin-Bin Li; Tai-Fang Gong
Journal:  Springerplus       Date:  2016-11-08

3.  Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility.

Authors:  Yuan-Yuan Hu; Xin-Ya Du; Ai-Ling Zhan; Lan Zhou; Qian Jiang; Yu-Ming Niu; Ming Shen
Journal:  Oncotarget       Date:  2016-07-26

4.  Genetic association between the cyclin-dependent kinase inhibitor gene p27/Kip1 polymorphism (rs34330) and cancer susceptibility: a meta-analysis.

Authors:  Xiao-Ke Cheng; Xue-Jun Wang; Xiao-Dong Li; Xue-Qun Ren
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

5.  Association between CD14 rs2569190 C>T polymorphism and ischemic stroke susceptibility: a meta-analysis based on 5,277 subjects.

Authors:  Yan-Qiong Wu; Shi-Yan Cheng; Xian-Cheng Xu; Wen-Cui Li
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-21       Impact factor: 2.570

Review 6.  Systemic immune responses after ischemic stroke: From the center to the periphery.

Authors:  Fan Wu; Zongchi Liu; Lihui Zhou; Di Ye; Yu Zhu; Kaiyuan Huang; Yuxiang Weng; Xiaoxing Xiong; Renya Zhan; Jian Shen
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

7.  Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis.

Authors:  Chi Zhang; Jing-Yu Huang; Zi-Qi He; Hong Weng
Journal:  Onco Targets Ther       Date:  2016-04-20       Impact factor: 4.147

8.  The association between rs16917496 T/C polymorphism of SET8 gene and cancer risk in Asian populations: a meta-analysis.

Authors:  Hui-Xia Wei; Guo-Xiang Tian; Ju-Kun Song; Lian-Jie Yang; Yu-Pei Wang
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

9.  Association Between Vitamin D Receptor Gene Polymorphisms and Polycystic Ovary Syndrome Risk: A Meta-Analysis.

Authors:  Yu-Ming Niu; Ya-Dong Wang; Guang-Bin Jiang; Gang Bai; Hong-Bo Chai; Xue-Feng Li; Yuan-Yuan Hu; Ming Shen
Journal:  Front Physiol       Date:  2019-01-10       Impact factor: 4.566

10.  Association between Interleukin-10 Gene Polymorphisms and Behcet's Disease Susceptibility: Evidence from a Meta-Analysis.

Authors:  Xue-Feng Li; Zhi-Zhen Huang; Yuan-Yuan Hu; Yu-Ming Niu; Jun-Wei Cai
Journal:  J Immunol Res       Date:  2020-06-19       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.